MANHATTAN — The Veterinary Health Center at Kansas State University is now offering regenerative medicine therapy, including platelet-rich plasma and animal stem cell therapies, for equine patients.

Just like in humans, animal stem cells are the precursors of normal tissue cells and can be found throughout the animal’s body, often enriched in the bone marrow and fat. Studies to date have shown that animal stem cell therapy is safe and has the potential to be effective in the treatment of multiple, acute and chronic inflammatory diseases. Platelet-rich plasma uses the effects of concentrated growth factors, released from the platelets, to enhance the healing process.

The Veterinary Health Center is working with Enso Discoveries, a regenerative medicine company based in Manhattan. Enso’s protocols were developed in collaboration with Chanran Ganta, a stem cell researcher and veterinary pathologist at the Kansas State Veterinary Diagnostic Laboratory.

“It is imperative to ensure that the stem cells collected from patients are viable, sterile, present in numbers shown to be clinically effective, and are safe for use in patients,” Ganta said